Home » Population Diagnostics, Empire Genomics Sign Co-Marketing Pact

Population Diagnostics, Empire Genomics Sign Co-Marketing Pact

Oct 11, 2006
NEW YORK (GenomeWeb News) - Population Diagnostics and Empire Genomics have signed a co-marketing agreement with the goal of developing molecular diagnostic tests, Population Diagnostics said today.
 
Under the terms of the “multifaceted” deal, EG of Buffalo, NY, will have access to PDI’s core technology platform for discovering copy number polymorphisms. EG will use PDI’s technology to support its internal and collaborative projects, as well as in service and supply relationships with third parties.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

When the Ailment You're Studying Becomes Personal

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

Irish Genomics Initiative Looks to Expand Into Scotland

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

Another Source of Data for 23andMe

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

This Week in PLOS

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.